Session:   

Bill

Home - Bills - Bill - Authors - Dates - Keywords - Tags - Locations

Measure SB 646
Authors Weber Pierson  
Subject Prenatal multivitamins.
Relating To relating to public health.
Title An act to add Chapter 4.5 (commencing with Section 110424) to Part 5 of Division 104 of the Health and Safety Code, relating to public health.
Last Action Dt 2025-10-11
State Chaptered
Status Chaptered
Active? Y
Vote Required Majority
Appropriation No
Fiscal Committee Yes
Local Program Yes
Substantive Changes None
Urgency No
Tax Levy No
Leginfo Link Bill
Actions
2025-10-11     Approved by the Governor.
2025-10-11     Chaptered by Secretary of State. Chapter 602, Statutes of 2025.
2025-09-23     Enrolled and presented to the Governor at 2 p.m.
2025-09-13     Assembly amendments concurred in. (Ayes 34. Noes 0. Page 3058.) Ordered to engrossing and enrolling.
2025-09-13     In Senate. Concurrence in Assembly amendments pending.
2025-09-13     Read third time. Passed. (Ayes 77. Noes 0. Page 3442.) Ordered to the Senate.
2025-09-13     Joint Rule 61(a)(14) and 51(a)(4) suspended. (Ayes 59. Noes 20. Page 3413.)
2025-09-09     Ordered to third reading.
2025-09-09     Read third time and amended.
2025-09-09     Joint Rule 61(a)(13) suspended. (Ayes 60. Noes 20. Page 3128.)
2025-09-05     Ordered to third reading.
2025-09-05     Read third time and amended.
2025-09-05     Assembly Rule 69(b)(1) suspended.
2025-09-02     Read second time. Ordered to third reading.
2025-08-29     From committee: Do pass. (Ayes 15. Noes 0.) (August 29).
2025-08-20     August 20 set for first hearing. Placed on APPR. suspense file.
2025-07-16     From committee: Do pass and re-refer to Com. on APPR. (Ayes 5. Noes 0.) (July 15). Re-referred to Com. on APPR.
2025-07-10     From committee with author's amendments. Read second time and amended. Re-referred to Com. on E.S & T.M.
2025-07-07     Read second time and amended. Re-referred to Com. on E.S & T.M.
2025-07-03     From committee: Do pass as amended and re-refer to Com. on E.S & T.M. (Ayes 15. Noes 0.) (July 1).
2025-06-16     From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH.
2025-06-05     Referred to Coms. on HEALTH and E.S & T.M.
2025-05-28     In Assembly. Read first time. Held at Desk.
2025-05-28     Read third time. Passed. (Ayes 38. Noes 0. Page 1305.) Ordered to the Assembly.
2025-05-23     Read second time. Ordered to third reading.
2025-05-23     From committee: Do pass. (Ayes 6. Noes 0. Page 1208.) (May 23).
2025-05-16     Set for hearing May 23.
2025-05-12     May 12 hearing: Placed on APPR. suspense file.
2025-05-02     Set for hearing May 12.
2025-05-01     From committee: Do pass and re-refer to Com. on APPR. (Ayes 8. Noes 0. Page 964.) (April 30). Re-referred to Com. on APPR.
2025-04-10     From committee with author's amendments. Read second time and amended. Re-referred to Com. on E.Q.
2025-04-08     Set for hearing April 30.
2025-04-03     From committee: Do pass and re-refer to Com. on E.Q. (Ayes 11. Noes 0. Page 636.) (April 2). Re-referred to Com. on E.Q.
2025-03-24     From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH.
2025-03-17     Set for hearing April 2.
2025-03-05     Referred to Coms. on HEALTH and E.Q.
2025-02-21     From printer. May be acted upon on or after March 23.
2025-02-20     Introduced. Read first time. To Com. on RLS. for assignment. To print.
Keywords
Tags
Versions
Chaptered     2025-10-11
Enrolled     2025-09-18
Amended Assembly     2025-09-09
Amended Assembly     2025-09-05
Amended Assembly     2025-07-10
Amended Assembly     2025-07-07
Amended Assembly     2025-06-16
Amended Senate     2025-04-10
Amended Senate     2025-03-24
Introduced     2025-02-20
Last Version Text
<?xml version="1.0" ?>
<ns0:MeasureDoc xmlns:html="http://www.w3.org/1999/xhtml" xmlns:ns0="http://lc.ca.gov/legalservices/schemas/caml.1#" xmlns:ns3="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" version="1.0" xsi:schemaLocation="http://lc.ca.gov/legalservices/schemas/caml.1# xca.1.xsd">
	


	<ns0:Description>
		<ns0:Id>20250SB__064690CHP</ns0:Id>
		<ns0:VersionNum>90</ns0:VersionNum>
		<ns0:History>
			<ns0:Action>
				<ns0:ActionText>INTRODUCED</ns0:ActionText>
				<ns0:ActionDate>2025-02-20</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>AMENDED_SENATE</ns0:ActionText>
				<ns0:ActionDate>2025-03-24</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>AMENDED_SENATE</ns0:ActionText>
				<ns0:ActionDate>2025-04-10</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>AMENDED_ASSEMBLY</ns0:ActionText>
				<ns0:ActionDate>2025-06-16</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>AMENDED_ASSEMBLY</ns0:ActionText>
				<ns0:ActionDate>2025-07-07</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>AMENDED_ASSEMBLY</ns0:ActionText>
				<ns0:ActionDate>2025-07-10</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>AMENDED_ASSEMBLY</ns0:ActionText>
				<ns0:ActionDate>2025-09-05</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>AMENDED_ASSEMBLY</ns0:ActionText>
				<ns0:ActionDate>2025-09-09</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>PASSED_ASSEMBLY</ns0:ActionText>
				<ns0:ActionDate>2025-09-13</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>PASSED_SENATE</ns0:ActionText>
				<ns0:ActionDate>2025-09-13</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>ENROLLED</ns0:ActionText>
				<ns0:ActionDate>2025-09-18</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>CHAPTERED</ns0:ActionText>
				<ns0:ActionDate>2025-10-11</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>APPROVED</ns0:ActionText>
				<ns0:ActionDate>2025-10-11</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>FILED</ns0:ActionText>
				<ns0:ActionDate>2025-10-11</ns0:ActionDate>
			</ns0:Action>
		</ns0:History>
		<ns0:LegislativeInfo>
			<ns0:SessionYear>2025</ns0:SessionYear>
			<ns0:SessionNum>0</ns0:SessionNum>
			<ns0:MeasureType>SB</ns0:MeasureType>
			<ns0:MeasureNum>646</ns0:MeasureNum>
			<ns0:MeasureState>CHP</ns0:MeasureState>
			<ns0:ChapterYear>2025</ns0:ChapterYear>
			<ns0:ChapterType>CHP</ns0:ChapterType>
			<ns0:ChapterSessionNum>0</ns0:ChapterSessionNum>
			<ns0:ChapterNum>602</ns0:ChapterNum>
		</ns0:LegislativeInfo>
		<ns0:AuthorText authorType="LEAD_AUTHOR">Introduced by Senator Weber Pierson</ns0:AuthorText>
		<ns0:Authors>
			<ns0:Legislator>
				<ns0:Contribution>LEAD_AUTHOR</ns0:Contribution>
				<ns0:House>SENATE</ns0:House>
				<ns0:Name>Weber Pierson</ns0:Name>
			</ns0:Legislator>
		</ns0:Authors>
		<ns0:Title>An act to add Chapter 4.5 (commencing with Section 110424) to Part 5 of Division 104 of the Health and Safety Code, relating to public health.</ns0:Title>
		<ns0:RelatingClause>public health</ns0:RelatingClause>
		<ns0:GeneralSubject>
			<ns0:Subject>Prenatal multivitamins.</ns0:Subject>
		</ns0:GeneralSubject>
		<ns0:DigestText>
			<html:p>Existing law, the Sherman Food, Drug, and Cosmetic Law, under the administration and enforcement of the State Department of Public Health, provides for the regulation of various subjects relating to the manufacturing, processing, labeling, advertising, and sale of food, drugs, and cosmetics. A violation of the Sherman Food, Drug, and Cosmetic Law is punishable as a misdemeanor.</html:p>
			<html:p>Existing law requires a manufacturer of baby food for sale or distribution in this state to test a representative sample of each production aggregate of the manufacturer’s final baby food product for toxic elements, as specified. Existing law requires a manufacturer to provide test results to any authorized agent of the department upon their request, as specified. Existing law requires a manufacturer of a final baby food product sold, manufactured, delivered, held, or
			 offered for sale in the state to provide specified information disclosures to consumers, including making publicly available on its internet website the name and level of each toxic element present in each production aggregate of the final baby food product. Existing law also prohibits a person or entity from selling in the state or manufacturing, delivering, holding, or offering for sale in the state any baby food that does not comply with these provisions.</html:p>
			<html:p>This bill would require, commencing January 1, 2027, a manufacturer of a bulk prenatal multivitamin product or packaged prenatal multivitamin product, as defined, that is sold, manufactured, delivered, held, or offered for sale in this state to test a representative sample of each lot of the manufacturer’s bulk prenatal multivitamin product or packaged prenatal multivitamin product for heavy metals, as specified. The bill would define “heavy metals” to mean arsenic, cadmium, lead, and mercury. The bill would
			 require both a manufacturer and brand owner to provide test results to an authorized agent of the department upon their request, as specified. The bill would, commencing January 1, 2027, require a brand owner of a packaged prenatal multivitamin product that is sold, manufactured, delivered, held, or offered for sale in the state, as specified, to disclose specified product information to the public, including, among other things, the heavy metal testing information. Commencing on or after January 1, 2027, for products shipped to retailers or consumers, the bill would require the outermost package of a packaged prenatal vitamin product and the product details page on an internet website where the product is sold to include a statement regarding heavy metal testing. The bill would prohibit a person from selling in the state or manufacturing, delivering, holding, or offering for sale in the state a prenatal multivitamin that does not comply with these provisions. By creating a new crime, the bill would impose a
			 state-mandated local program.</html:p>
			<html:p>The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.</html:p>
			<html:p>This bill would provide that no reimbursement is required by this act for a specified reason.</html:p>
		</ns0:DigestText>
		<ns0:DigestKey>
			<ns0:VoteRequired>MAJORITY</ns0:VoteRequired>
			<ns0:Appropriation>NO</ns0:Appropriation>
			<ns0:FiscalCommittee>YES</ns0:FiscalCommittee>
			<ns0:LocalProgram>YES</ns0:LocalProgram>
		</ns0:DigestKey>
		<ns0:MeasureIndicators>
			<ns0:ImmediateEffect>NO</ns0:ImmediateEffect>
			<ns0:ImmediateEffectFlags>
				<ns0:Urgency>NO</ns0:Urgency>
				<ns0:TaxLevy>NO</ns0:TaxLevy>
				<ns0:Election>NO</ns0:Election>
				<ns0:UsualCurrentExpenses>NO</ns0:UsualCurrentExpenses>
				<ns0:BudgetBill>NO</ns0:BudgetBill>
				<ns0:Prop25TrailerBill>NO</ns0:Prop25TrailerBill>
			</ns0:ImmediateEffectFlags>
		</ns0:MeasureIndicators>
	</ns0:Description>
	<ns0:Bill id="bill">
		<ns0:Preamble>The people of the State of California do enact as follows:</ns0:Preamble>
		<ns0:BillSection id="id_4BB82E98-BA45-4D4B-8C00-CA671457DA29">
			<ns0:Num>SECTION 1.</ns0:Num>
			<ns0:ActionLine action="IS_ADDED" ns3:href="urn:caml:codes:HSC:caml#xpointer(%2Fcaml%3ALawDoc%2Fcaml%3ACode%2Fcaml%3ALawHeading%5B%40type%3D'DIVISION'%20and%20caml%3ANum%3D'104.'%5D%2Fcaml%3ALawHeading%5B%40type%3D'PART'%20and%20caml%3ANum%3D'5.'%5D%2Fcaml%3ALawHeading%5B%40type%3D'CHAPTER'%20and%20caml%3ANum%3D'4.5.'%5D)" ns3:label="fractionType: LAW_SPREAD||commencingWith: 110424" ns3:type="locator">
				Chapter 4.5 (commencing with Section 110424) is added to Part 5 of Division 104 of the 
				<ns0:DocName>Health and Safety Code</ns0:DocName>
				, to read:
			</ns0:ActionLine>
			<ns0:Fragment>
				<ns0:LawHeading id="id_141E69BA-B145-4F97-839C-BEE5149BAFA7" type="CHAPTER">
					<ns0:Num>4.5.</ns0:Num>
					<ns0:LawHeadingVersion id="id_D9E22B66-68FF-46F1-8022-C96ED3DD7C05">
						<ns0:LawHeadingText>Prenatal Multivitamins</ns0:LawHeadingText>
					</ns0:LawHeadingVersion>
					<ns0:LawSection id="id_5EAE805D-D7AF-4D26-AB0E-12C271F7C7F6">
						<ns0:Num>110424.</ns0:Num>
						<ns0:LawSectionVersion id="id_18132382-12DD-49FB-AC65-EF0289673AA7">
							<ns0:Content>
								<html:p>For purposes of this chapter, the following definitions apply:</html:p>
								<html:p>
									(a)
									<html:span class="EnSpace"/>
									“Brand owner” means the person who owns or licenses the trademark that is the most prominent trademark on the principal display panel of the prenatal multivitamin product label. The manufacturer of a prenatal multivitamin for another person who owns the trademark is not the brand owner.
								</html:p>
								<html:p>
									(b)
									<html:span class="EnSpace"/>
									“Bulk prenatal multivitamin product” means the bulk prenatal multivitamin product in finished dosage form before it is packaged and labeled. Bulk prenatal multivitamin product does not mean the constituent ingredients of prenatal multivitamins.
								</html:p>
								<html:p>
									(c)
									<html:span class="EnSpace"/>
									“Heavy metals” means arsenic, cadmium, lead, and mercury.
								</html:p>
								<html:p>
									(d)
									<html:span class="EnSpace"/>
									“Lot” means a batch, or a specific identified portion of a batch, that is uniform and is intended to meet specifications for identity, purity, strength, and composition or, in the case of a dietary supplement produced by continuous process, a specific identified amount produced in a specified unit of time or quantity in a manner that is uniform and that is intended to meet specifications for identity, purity, strength, and composition.
								</html:p>
								<html:p>
									(e)
									<html:span class="EnSpace"/>
									“Manufacturer” means a person who is either of the following:
								</html:p>
								<html:p>
									(1)
									<html:span class="EnSpace"/>
									A brand owner who manufactures, as defined in Section 109970, a prenatal multivitamin.
								</html:p>
								<html:p>
									(2)
									<html:span class="EnSpace"/>
									A person who manufactures, as defined in Section 109970, but is not the brand owner of a prenatal multivitamin.
								</html:p>
								<html:p>
									(f)
									<html:span class="EnSpace"/>
									“Packaged prenatal multivitamin product” means the bulk prenatal multivitamin product that has been packaged for sale or distribution to the public or health care
						  professionals. The product label may include, but is not required to have, a unique universal product code (UPC).
								</html:p>
								<html:p>
									(g)
									<html:span class="EnSpace"/>
									“Prenatal multivitamin” means a dietary supplement that contains one or more vitamins or minerals and is represented or purported to be specifically used, or intended to be used, to support the health of an individual who is pregnant, planning to become pregnant, or lactating.
						  Prenatal multivitamins may be in the form of, but are not limited to, capsules, tablets, gummies, liquids, or powder.
								</html:p>
								<html:p>
									(h)
									<html:span class="EnSpace"/>
									“Product label” means a display of written, printed, or graphic material that is affixed to a product’s immediate container.
								</html:p>
								<html:p>
									(i)
									<html:span class="EnSpace"/>
									“Product shelf life” means the time, measured in the number of months, as printed on the product label, between the date of manufacture and the expiration date for a packaged prenatal multivitamin product.
								</html:p>
								<html:p>
									(j)
									<html:span class="EnSpace"/>
									“Proficient laboratory” is a laboratory that meets the criteria listed in subdivision (b) of Section 110424.1.
								</html:p>
								<html:p>
									(k)
									<html:span class="EnSpace"/>
									“Representative sample” means a sample that consists of a number of
						  units that are drawn based on rational criteria, such as random sampling, and intended to ensure that the sample accurately portrays the material being sampled.
								</html:p>
							</ns0:Content>
						</ns0:LawSectionVersion>
					</ns0:LawSection>
					<ns0:LawSection id="id_70C431D8-6F92-4910-93FF-438A7C302839">
						<ns0:Num>110424.1.</ns0:Num>
						<ns0:LawSectionVersion id="id_F332A597-F030-4C78-891A-F311040381F4">
							<ns0:Content>
								<html:p>
									(a)
									<html:span class="EnSpace"/>
									Commencing January 1, 2027, a manufacturer of a bulk prenatal multivitamin product or a packaged prenatal multivitamin product that is sold, manufactured, delivered, held, or offered for sale in the state shall test a representative sample of each lot of the manufacturer’s bulk prenatal multivitamin product or packaged prenatal multivitamin product at a proficient laboratory for heavy metals.
								</html:p>
								<html:p>
									(b)
									<html:span class="EnSpace"/>
									The proficient laboratory, including a manufacturer’s in-house laboratory, that analyzes the bulk prenatal multivitamin product or packaged prenatal multivitamin product for heavy metals shall meet all of the following criteria:
								</html:p>
								<html:p>
									(1)
									<html:span class="EnSpace"/>
									(A)
									<html:span class="EnSpace"/>
									Be accredited under the standards of the International Organization for Standardization’s (ISO) and the International Electrotechnical Commission’s (IEC) ISO/IEC 17025:2017 international standard regarding the general requirements for the competence of testing and calibration laboratories as they pertain to the testing of heavy metals.
								</html:p>
								<html:p>
									(B)
									<html:span class="EnSpace"/>
									To the extent such standards contradict the requirements of any federal regulations promulgated pursuant to the Federal Food, Drug, and Cosmetic Act pertinent to supplements, the federal regulations shall control.
								</html:p>
								<html:p>
									(2)
									<html:span class="EnSpace"/>
									Use an analytical method that is at least as sensitive and specific as that described in
						  Section 4.7 of the United States Food and Drug Administration’s Elemental Analysis Manual for Food and Related Products: Inductively Coupled Plasma-Mass Spectrometric Determination of Arsenic, Cadmium, Chromium, Lead, Mercury, and Other Elements in Food Using Microwave Assisted Digestion.
								</html:p>
								<html:p>
									(3)
									<html:span class="EnSpace"/>
									Demonstrate proficiency in quantifying each heavy metal to 10 micrograms or less of the
						  heavy metal to kilogram of supplement (μg/kg) through an independent proficiency test. Proficiency means that a laboratory achieves a z-score that is less than, or equal to, plus or minus two (≤ ±2).
								</html:p>
								<html:p>
									(c)
									<html:span class="EnSpace"/>
									Both manufacturers and brand owners shall provide test results to an authorized agent of the department upon their
						  request pursuant to Article 2 (commencing with Section 110140) of Chapter 2 or Article 11 (commencing with Section 111015) of Chapter 5. If a brand owner does not manufacture the bulk prenatal multivitamin product or packaged prenatal multivitamin product, they may comply with this subdivision by providing the test results of the manufacturer they use to produce the bulk prenatal multivitamin product or packaged prenatal multivitamin product.
								</html:p>
							</ns0:Content>
						</ns0:LawSectionVersion>
					</ns0:LawSection>
					<ns0:LawSection id="id_81094945-A8B7-4ACF-968A-C236A875146F">
						<ns0:Num>110424.2.</ns0:Num>
						<ns0:LawSectionVersion id="id_EE82B441-6519-4B9B-AF7A-C11774FA508C">
							<ns0:Content>
								<html:p>Commencing January 1, 2027, a brand owner of a packaged prenatal multivitamin product that is sold, manufactured, delivered, held, or offered for sale in the state, including, without limitation, prenatal multivitamins that are sold by a retailer or that are sold directly to consumers, shall disclose product information to the public consistent with all of the following:</html:p>
								<html:p>
									(a)
									<html:span class="EnSpace"/>
									(1)
									<html:span class="EnSpace"/>
									Make publicly available on the brand owner’s internet website, for the duration of the product shelf life for a packaged prenatal multivitamin product plus one month, all of the following:
								</html:p>
								<html:p>
									(A)
									<html:span class="EnSpace"/>
									The name and level of each heavy metal present in each lot of a packaged prenatal multivitamin product.
								</html:p>
								<html:p>
									(B)
									<html:span class="EnSpace"/>
									Information from the product’s supplement facts panel, including the amount per serving of each ingredient.
								</html:p>
								<html:p>
									(C)
									<html:span class="EnSpace"/>
									The statement:
								</html:p>
								<html:p>“Prenatal multivitamins containing certain minerals critical to support an expectant person’s health and proper development of their fetus may contain trace levels of heavy metals that occur in the environment naturally or from human activities. The levels of heavy metals in prenatal multivitamin ingredients may vary depending on whether and at what levels the prenatal multivitamin contains these ingredients, as well as the location from which the ingredients are sourced. Certain foods containing
						  minerals critical to support an expectant person’s health and proper development of their fetus may also contain heavy metals. For more information, speak with your physician about choosing a prenatal multivitamin that meets your specific nutrient needs.”</html:p>
								<html:p>
									(2)
									<html:span class="EnSpace"/>
									The information required in paragraph (1) shall all be provided on the same web page.
								</html:p>
								<html:p>
									(b)
									<html:span class="EnSpace"/>
									The heavy metal testing information shall be available to the public without having to provide a UPC number, a lot number, or a proof of purchase.
								</html:p>
								<html:p>
									(c)
									<html:span class="EnSpace"/>
									Provide descriptive information on its internet website to enable accurate identification of the packaged prenatal multivitamin product by the public, including information that makes the levels of heavy metals available to
						  the public by lot.
						  Descriptive information may include, but is not limited to, product name, UPC, size, or lot numbers.
								</html:p>
								<html:p>
									(d)
									<html:span class="EnSpace"/>
									An internet website hyperlink to the United States Food and Drug Administration (FDA) where the public can find the most recent FDA internet website relating to heavy metals in food.
								</html:p>
								<html:p>
									(e)
									<html:span class="EnSpace"/>
									On the brand owner’s internet website describing a packaged prenatal multivitamin product, include a prominent statement that reads “For information about heavy metal testing on this product” followed by a hyperlink to the internet website that contains the publicly available test results.
								</html:p>
								<html:p>
									(f)
									<html:span class="EnSpace"/>
									(1)
									<html:span class="EnSpace"/>
									For a product sold in a retail store that is shipped to retailers
						  on or after January 1, 2027, the outermost “package,” as defined in Section 1459(b) of Title 15 of the United States Code, of a packaged prenatal multivitamin product shall include a statement that reads: “For information about heavy metal testing on this product, visit” followed by the web address where the information required by subdivision
						  (a) is posted.
								</html:p>
								<html:p>
									(2)
									<html:span class="EnSpace"/>
									For a product sold online or directly to consumers that is shipped to consumers on or after January 1, 2027, the product details page for the product, on an internet website where the product is sold, shall include a statement that reads: “For information about heavy metal testing on this product, visit” followed by a hyperlink to the internet website where the information required by subdivision (a) is posted.
								</html:p>
								<html:p>
									(3)
									<html:span class="EnSpace"/>
									On or after January 1, 2030, a person shall not sell in the state or manufacture, deliver, hold, or offer for sale in the state a prenatal multivitamin, including, without limitation, a prenatal multivitamin that is sold by a retailer or that is sold directly to consumers, that does not include
						  the packaging or online statements specified in paragraphs (1) and (2).
								</html:p>
							</ns0:Content>
						</ns0:LawSectionVersion>
					</ns0:LawSection>
					<ns0:LawSection id="id_353E5AF7-3EA5-416F-AEC9-598529B69053">
						<ns0:Num>110424.3.</ns0:Num>
						<ns0:LawSectionVersion id="id_62DF09CE-DE9F-4B35-8AEF-F7A6BDA7F63E">
							<ns0:Content>
								<html:p>A person shall not sell in the state or manufacture, deliver, hold, or offer for sale in the state a prenatal multivitamin, including, without limitation, a prenatal multivitamin that is sold by a retailer or
						  that is sold directly to consumers, that does not comply with the requirements described in this chapter.</html:p>
							</ns0:Content>
						</ns0:LawSectionVersion>
					</ns0:LawSection>
				</ns0:LawHeading>
			</ns0:Fragment>
		</ns0:BillSection>
		<ns0:BillSection id="id_782CC439-F135-494D-9484-687D370ECCFB">
			<ns0:Num>SEC. 2.</ns0:Num>
			<ns0:Content>
				<html:p>
					No reimbursement is required by this act pursuant to Section 6 of Article XIII
					<html:span class="ThinSpace"/>
					B of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIII
					<html:span class="ThinSpace"/>
					B of the California Constitution.
				</html:p>
			</ns0:Content>
		</ns0:BillSection>
	</ns0:Bill>
</ns0:MeasureDoc>
Last Version Text Digest Existing law, the Sherman Food, Drug, and Cosmetic Law, under the administration and enforcement of the State Department of Public Health, provides for the regulation of various subjects relating to the manufacturing, processing, labeling, advertising, and sale of food, drugs, and cosmetics. A violation of the Sherman Food, Drug, and Cosmetic Law is punishable as a misdemeanor. Existing law requires a manufacturer of baby food for sale or distribution in this state to test a representative sample of each production aggregate of the manufacturer’s final baby food product for toxic elements, as specified. Existing law requires a manufacturer to provide test results to any authorized agent of the department upon their request, as specified. Existing law requires a manufacturer of a final baby food product sold, manufactured, delivered, held, or offered for sale in the state to provide specified information disclosures to consumers, including making publicly available on its internet website the name and level of each toxic element present in each production aggregate of the final baby food product. Existing law also prohibits a person or entity from selling in the state or manufacturing, delivering, holding, or offering for sale in the state any baby food that does not comply with these provisions. This bill would require, commencing January 1, 2027, a manufacturer of a bulk prenatal multivitamin product or packaged prenatal multivitamin product, as defined, that is sold, manufactured, delivered, held, or offered for sale in this state to test a representative sample of each lot of the manufacturer’s bulk prenatal multivitamin product or packaged prenatal multivitamin product for heavy metals, as specified. The bill would define “heavy metals” to mean arsenic, cadmium, lead, and mercury. The bill would require both a manufacturer and brand owner to provide test results to an authorized agent of the department upon their request, as specified. The bill would, commencing January 1, 2027, require a brand owner of a packaged prenatal multivitamin product that is sold, manufactured, delivered, held, or offered for sale in the state, as specified, to disclose specified product information to the public, including, among other things, the heavy metal testing information. Commencing on or after January 1, 2027, for products shipped to retailers or consumers, the bill would require the outermost package of a packaged prenatal vitamin product and the product details page on an internet website where the product is sold to include a statement regarding heavy metal testing. The bill would prohibit a person from selling in the state or manufacturing, delivering, holding, or offering for sale in the state a prenatal multivitamin that does not comply with these provisions. By creating a new crime, the bill would impose a state-mandated local program.